Shot tracker that remembers.
Body map for site rotation, pen-click dose calculator, smart reminders synced to your cycle.
Symptra is the first GLP-1 tracker that connects what you ate to how you feel. Log your shot, your meals and your symptoms. Then watch the patterns surface. Built for Ozempic, Wegovy, Mounjaro and Zepbound.
Most GLP-1 users juggle three apps for their shot, their food, and how they feel. Symptra does all of it, and shows you the connections.
Body map for site rotation, pen-click dose calculator, smart reminders synced to your cycle.
Rate nausea 1–10, tap suspected triggers, capture mood, energy and food noise, even when you feel awful.
No calorie counting. Just categories, BRAT-safe flags, and quick entry in three taps.
After two weeks Symptra tells you which foods triggered nausea and when your cycle peaks.
Other apps track your data. Symptra tells you what it means. Log two weeks of food, shots and symptoms. Then watch the connections surface.

Fried food → nausea within 4 hours, in 8 of your last 10 cycles.
Days 2–3 post-injection consistently bring higher symptom scores than the rest of your cycle.
Skipping meals correlates with worse nausea, even on rest days.
We just built the tool. Stories from people logging with Symptra since beta.
"The mirror lies on a bad day. The cycle chart in Symptra told me the truth. Day 3 was always going to be brutal, and day 5 was the bounce."
"First beach trip in years where I wasn't planning around being seen. Symptra got me through the weeks I almost gave up."
"I finally get a clear view of what I'm eating and what I actually need to get through the day. Without the calorie shame."
"Symptra feels like a tool that supports you rather than pressures you. I feel in control, and finally sleeping through the night."
Semaglutide, tirzepatide, liraglutide. Injectable or oral. If it's a GLP-1, Symptra speaks its language.
Symptra is independent. Not affiliated with Novo Nordisk or Eli Lilly. Ozempic®, Wegovy®, Mounjaro® and Zepbound® are trademarks of their respective owners.
We don't want your health data. We just want the app to be useful.
Everything is stored on-device. No servers, no syncing to the cloud unless you turn it on.
No email, no sign-up form, no password to forget. Open the app and start.
We measure feature usage in aggregate to improve Symptra. No ad networks, no personal data sold, no profiling.
Every feature works without internet. You only need a connection to update the app.
Plain-language guides for everything the clinic forgot to tell you. Written from what 372K GLP-1 users have actually figured out.
The starter dose is roughly 1/10 of the therapeutic dose. Week one is your body learning the signal, not the medication failing.
Nausea, constipation, reflux. The strategies that work for 74–84% of GLP-1 users, and which ones to skip.
Slow titration isn't a mistake. It's the only path to a tolerable therapeutic dose. The science, explained simply.
GLP-1 quietly turns down thirst. Why electrolytes, not water, are usually the missing piece on day four.
The constant mental soundtrack about food just stops. The most transformative experience people describe on GLP-1, and the grief that can follow.
Appix is a tiny team that builds mobile apps from the ground up. Flutter when speed matters, Kotlin and Swift when it has to feel native. We blend traditional craft with AI-assisted development, which means faster iteration and more time on the details that make an app feel right.